Neil Campbell

Neil Campbell

Chairman chez Mosaigen LLC

64 ans
Health Technology
Consumer Services
Health Services

Profil

Neil J.
Campbell
is the founder of SuperNova Diagnostics, Inc. (2011).
He currently holds the position of Chairman at Mosaigen LLC and Director at Life Sciences Pennsylvania.
Dr. Campbell has previously held positions such as President, Chief Executive Officer & Director at Helomics Corp.
(2014-2016) and Marizyme, Inc. (2020-2021), President, Chief Executive Officer & Director at Blue Water Biotech, Inc. and Onconetix, Inc., and Director at Lakewood-Amedex, Inc. He was also the President & Chief Operating Officer at CASI Pharmaceuticals, Inc. Dr. Campbell has a doctorate from The University of Liverpool, an undergraduate degree from Norwich University, and a graduate degree and MBA from Webster University (United Kingdom).

Postes actifs de Neil Campbell

SociétésPosteDébut
Director/Board Member -
Mosaigen LLC Chairman -
Tous les postes actifs de Neil Campbell

Anciens postes connus de Neil Campbell

SociétésPosteFin
ONCONETIX, INC. Chief Executive Officer 10/01/2024
MARIZYME, INC. Chief Executive Officer 18/03/2021
Chief Executive Officer 09/11/2016
Chief Executive Officer -
Director/Board Member -
Voir l'expérience en détail de Neil Campbell

Formation de Neil Campbell

The University of Liverpool Doctorate Degree
Norwich University Undergraduate Degree
Webster University (United Kingdom) Graduate Degree

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Voir l'expérience en détail de Neil Campbell

Relations

42

Relations au 1er degré

12

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Voir le réseau personnel

Sociétés liées

Sociétés cotées2
MARIZYME, INC.

Health Technology

ONCONETIX, INC.

Health Technology

Entreprise privées7

Health Technology

Health Services

Commercial Services

SuperNova Diagnostics, Inc.

Health Technology

Health Technology

Health Technology

Mosaigen LLC

Voir les connexions sociétés
  1. Bourse
  2. Insiders
  3. Neil Campbell